These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8795267)

  • 1. Synthesis and biological activity of 4-amino-5-chloro-2-ethoxy-3-hydroxybenzamides, metabolites of a new gastroprokinetic agent, mosapride.
    Kato S; Morie T; Yoshida N
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1484-92. PubMed ID: 8795267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent.
    Kato S; Morie T; Yoshida N
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):699-702. PubMed ID: 7600620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of the optical isomers of (+/-)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl]benzamide (mosapride).
    Morie T; Kato S; Harada H; Yoshida N; Matsumoto J
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):877-82. PubMed ID: 8020122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel benzamides as selective and potent gastrokinetic agents. 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl] benzamide citrate (AS-4370) and related compounds.
    Kato S; Morie T; Kon T; Yoshida N; Karasawa T; Matsumoto J
    J Med Chem; 1991 Feb; 34(2):616-24. PubMed ID: 1995885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological effects of the gastroprokinetic agent mosapride citrate].
    Yoshida N
    Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthesis and biological evaluation of a new bioactive metabolite of mosapride as a potential gastroprokinetic agent.
    Yao J; Li K; Song Y; He Z; Liu Z; Zhao L; Wang S
    Future Med Chem; 2019 Jan; 11(1):21-32. PubMed ID: 30526030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzamides as selective and potent gastrokinetic agents. III. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-methoxy- and 2-ethoxy-N-[(4-substituted 2-morpholinyl)methyl]-benzamides.
    Kato S; Morie T; Harada H; Yoshida N; Matsumoto J
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):652-60. PubMed ID: 1535291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokinetic effect of the 5-HT4R agonist mosapride on canine gastric motility.
    Tsukamoto A; Ohno K; Maeda S; Nakashima K; Fukushima K; Fujino Y; Tsujimoto H
    J Vet Med Sci; 2011 Dec; 73(12):1635-7. PubMed ID: 21785238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxybenzamides with six- and seven-membered heteroalicycles as potential gastroprokinetic agents.
    Morie T; Kato S; Harada H; Yoshida N; Fujiwara I; Matsumoto J
    Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1137-47. PubMed ID: 7586057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 5-hydroxytryptamine 4 (5-HT4) receptor agonists. Synthesis and gastroprokinetic activity of 4-amino-N-[2-(1-aminocycloalkan-1-yl)ethyl]-5-chloro-2-methoxybenzamide s.
    Suzuki T; Imanishi N; Itahana H; Watanuki S; Miyata K; Ohta M; Nakahara H; Yamagiwa Y; Mase T
    Chem Pharm Bull (Tokyo); 1998 Jul; 46(7):1116-24. PubMed ID: 9692218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mosapride on ruminal motility in cattle.
    Arai S; Haritani M; Sawada H; Kimura K
    J Vet Med Sci; 2019 Jul; 81(7):1017-1020. PubMed ID: 31155551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of LC-MS/MS for the identification of a polar impurity in mosapride, a gastroprokinetic drug.
    Kumar YR; Moses Babu J; Sarma MS; Seshidhar B; Reddy SS; Reddy GS; Vyas K
    J Pharm Biomed Anal; 2003 Jun; 32(2):361-8. PubMed ID: 12763547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
    Becker DP; Flynn DL; Shone RL; Gullikson G
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5509-12. PubMed ID: 15482914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents.
    Kato S; Fujiwara I; Yoshida N
    Med Res Rev; 1999 Jan; 19(1):25-73. PubMed ID: 9918193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the effects of mosapride on motility of Guinea pig stomach, ileum, and colon.
    Ji SW; Park HJ; Cho JS; Lim JH; Lee SI
    Yonsei Med J; 2003 Aug; 44(4):653-64. PubMed ID: 12950122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.
    Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T
    Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.
    Kato S; Morie T; Hino K; Kon T; Naruto S; Yoshida N; Karasawa T; Matsumoto J
    J Med Chem; 1990 May; 33(5):1406-13. PubMed ID: 2139471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.